In predicaments where you may possibly have to have entry to a medically-needed drug for a serious or daily life-threatening condition exactly where there's no current market authorized drug accessible in copyright and for which different traditional therapies have failed or are unsuitable, Health copyright's Distinctive Accessibility Programme (SA